Martin H Stradner
Overview
Explore the profile of Martin H Stradner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alunno A, Carubbi F, Ritschl V, Cornec D, Zenz S, Vieira A, et al.
Joint Bone Spine
. 2024 Jan;
91(4):105695.
PMID: 38290661
No abstract available.
2.
Hodl I, Sallegger C, Forstner P, Sareban N, Moritz M, Dreo B, et al.
Microbes Infect
. 2023 Jan;
25(4):105103.
PMID: 36681177
B-cell depleting therapies result in diminished humoral immunity following vaccination against COVID-19, but our understanding on the impact on cellular immune responses is limited. Here, we performed a detailed analysis...
3.
Jud P, Verheyen N, Stradner M, Dejaco C, Szolar D, Thonhofer R, et al.
Rheumatol Int
. 2022 Aug;
43(3):477-485.
PMID: 35996028
Aortic dilatation (AD) occurs in up to 30% of patients with giant cell arteritis (GCA). Reliable biomarkers for AD development, however, are still absent. The aim of this exploratory study...
4.
Koch L, Plaschg K, Talakic E, Stradner M
Dermatologie (Heidelb)
. 2022 Aug;
73(12):974-976.
PMID: 35925216
No abstract available.
5.
Callegher S, Giovannini I, Zenz S, Manfre V, Stradner M, Hocevar A, et al.
Ther Adv Musculoskelet Dis
. 2022 May;
14:1759720X221100295.
PMID: 35634352
Primary Sjögren's syndrome (pSS) is a heterogeneous disease characterised by a wide spectrum of manifestations that vary according to the different stages of the disease and among different subsets of...
6.
Barth D, Stanzer S, Spiegelberg J, Bauernhofer T, Absenger G, Szkandera J, et al.
Front Immunol
. 2022 Apr;
13:840207.
PMID: 35432362
Background: Immune checkpoint inhibitors (ICIs) have revolutionized systemic anti-tumor treatments across different types of cancer. Nevertheless, predictive biomarkers regarding treatment response are not routinely established yet. Apart from T-lymphocytes, the...
7.
Ginthor N, Artinger K, Pollheimer M, Stradner M, Eller K
Clin Kidney J
. 2022 Feb;
15(3):564-566.
PMID: 35211311
Immunoglobulin G4 (IgG4)-releated disease is typically associated with interstitial nephritis, but rare cases of idiopathic membranous nephropathy as a renal manifestation have been described. Obinutuzumab was successfully used in refractory...
8.
Schulz E, Hodl I, Forstner P, Hatzl S, Sareban N, Moritz M, et al.
Front Immunol
. 2021 Dec;
12:803742.
PMID: 34950155
Immunocompromised patients are considered high-risk and prioritized for vaccination against COVID-19. We aimed to analyze B-cell subsets in these patients to identify potential predictors of humoral vaccination response. Patients (n=120)...
9.
Hedar A, Stradner M, Roessler A, Goswami N
J Clin Med
. 2021 Oct;
10(19).
PMID: 34640445
Autoimmune rheumatic diseases (AIRDs) with unknown etiology are increasing in incidence and prevalence. Up to 5% of the population is affected. AIRDs include rheumatoid arthritis, system lupus erythematosus, systemic sclerosis,...
10.
Husic R, Finzel S, Stradner M, Dreu M, Hofmeister A, Beham-Schmid C, et al.
Rheumatology (Oxford)
. 2021 Jul;
61(SI):SI73-SI80.
PMID: 34244721
Objective: To compare structural findings between US, micro-CT (µCT) and histology in people with OA of the hands. Methods: We analysed DIP and PIP joints of 31 fingers from 15...